i-gel® from Intersurgical: clinical evidence listing

A comprehensive list of all known published clinical evidence on the device

Bilateral pneumonectomy with difficult airway managed by using a combination of i-gel and EZ-Blocker

Ueshima H, Otake H. J Clin Anesth. 2016 Nov;34:516

Report of a successful case using i-gel insertion after two failed attempts at intubation with a video laryngoscope on a 73-year-old female with hypertension and a difficult airway.

Link to abstract

Addressing the challenges of paramedic recruitment and engagement in Airways-2

Pilbery R, Green J, Hall H, Whitley G. Emerg Med J 2016; 33e12

Report into the three main challenges facing recruitment for the Airways-2 trial (comparison of i-gel against tracheal intubation in patients suffering OHCA). 

Link to abstract.

A randomised trial to compare i‑gel and ProSeal™ laryngeal mask airway for airway management in paediatric patients

Nirupa R, Gombar S, Ahuja V, Sharma P. Indian J Anaesth. 2016 Oct;60(10):726-731

Prospective, randomised controlled study on 100 patients, with the primary outcome being leak pressure assessed at five minutes. i-gel recorded 'superior' pressure and shorter insertion times compared to ProSeal.

Link to abstract

What are the factors associated with successful I-gel™ insertion and uneventful anaesthesia in children under age two?

Magne C, Pichenot V, Didier P, Bérard L, Lejus-Bourdeau C. Anaesth Crit Care Pain Med. 2016 Sep 23

Size 1 and 1.5 were used in this study on patients under the age of two. Successful insertion at the first attempt was recorded in 75% of cases.

Link to abstract

Design and implementation of the AIRWAYS-2 trial

Taylor J, Black S, Brett S, Kirby K, Nolan JP, Reeves BC, Robinson M, Rogers CA, Scott LJ, South A, Stokes EA, Thomas M, Voss S, Wordsworth S, Benger JR. Resuscitation. 2016 Sep 30. pii: S0300-9572(16)30476-2

Patient enrollment began in June 2015 for this study comparing the use by paramedics of the i-gel against endotracheal intubation in OHCA in the UK. The primary outcome is the modified Rankin Scale score at hospital discharge. The trial will enrol 9070 patients over two years.

Link to abstract.